News Focus
News Focus
icon url

WorstLuck

05/04/22 2:34 PM

#242337 RE: DewDiligence #242335

AMRN

Is the company viable at all with the IP they have? Seems like they have had the short end of the stick from day one.
icon url

north40000

05/05/22 10:04 AM

#242352 RE: DewDiligence #242335

PFE approached Amarin’s partner, HLS, in Canada with a collaboration proposal to sell/market Vascepa. Quarter revenue and earnings for HLS show a marked increase. There is a message there somewhere for Amarin management and shareholders.